The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-08-01
著者
-
WAN Yu-Jui
Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center
-
Wan Yu-jui
Department Of Pathology Harbor-ucla Medical Center
-
Wan Yu-jui
Department Of Pharmacology Toxicology And Therapeutics The University Of Kansas Medical Center
-
Nie Yu-qiang
Department Of Gastroenterology And Hepatology Guangzhou Institute Of Clinical Medicine Guangzhou First Municipal People's Hospital Guangzhou Medical College
-
Li Yu-yuan
Department Of Gastroenterology And Hepatology Guangzhou Institute Of Clinical Medicine Guangzhou First Municipal People's Hospital Guangzhou Medical College
-
CAO Chuang-Yu
Department of Gastroenterology and Hepatology, Guangzhou Institute of Clinical Medicine, Guangzhou First Municipal People's Hospital, Guangzhou Medical College
-
ZHOU Yong-Jian
Department of Gastroenterology and Hepatology, Guangzhou Institute of Clinical Medicine, Guangzhou First Municipal People's Hospital, Guangzhou Medical College
-
Cao Chuang-yu
Department Of Gastroenterology And Hepatology Guangzhou Institute Of Clinical Medicine Guangzhou First Municipal People's Hospital Guangzhou Medical College
-
Zhou Yong-jian
Department Of Gastroenterology And Hepatology Guangzhou Institute Of Clinical Medicine Guangzhou First Municipal People's Hospital Guangzhou Medical College
関連論文
- Gender Disparity of Hepatic Lipid Homoeostasis Regulated by the Circadian Clock
- Regulation of peroxisome proliferator activated receptor α-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice
- Pathogenesis of mallory body formation:studies using the drug-primed mouse model
- Mouse model of hepatocellular hyperplastic nodule formation characterization of mRNA expression
- Hepatocyte nuclear factor 1 mediates the cell density associated induction of the α-fetoprotein gene
- The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease